A randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy (Q41267389)
Jump to navigation
Jump to search
scientific article published on April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy |
scientific article published on April 2015 |
Statements
1 reference
A randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy (English)
1 reference
Thor Ostenfeld
1 reference
Alok Krishen
1 reference
Robert Y Lai
1 reference
Jonathan Bullman
1 reference
Joanne Green
1 reference
Praveen Anand
1 reference
Joachim Scholz
1 reference
Madeline Kelly
1 reference
1 April 2015
1 reference
1 reference
Identifiers
1 reference